LLY

806.87

-1.43%↓

JNJ

155.12

-1.13%↓

ABBV

190.75

+0.09%↑

NVO

76.95

-3.5%↓

UNH

307.68

-1.78%↓

LLY

806.87

-1.43%↓

JNJ

155.12

-1.13%↓

ABBV

190.75

+0.09%↑

NVO

76.95

-3.5%↓

UNH

307.68

-1.78%↓

LLY

806.87

-1.43%↓

JNJ

155.12

-1.13%↓

ABBV

190.75

+0.09%↑

NVO

76.95

-3.5%↓

UNH

307.68

-1.78%↓

LLY

806.87

-1.43%↓

JNJ

155.12

-1.13%↓

ABBV

190.75

+0.09%↑

NVO

76.95

-3.5%↓

UNH

307.68

-1.78%↓

LLY

806.87

-1.43%↓

JNJ

155.12

-1.13%↓

ABBV

190.75

+0.09%↑

NVO

76.95

-3.5%↓

UNH

307.68

-1.78%↓

Search

Alkermes PLC

Geschlossen

BrancheGesundheitswesen

29.4 -1.41

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

29.24

Max

30.03

Schlüsselkennzahlen

By Trading Economics

Einkommen

-124M

22M

Verkäufe

-123M

307M

KGV

Branchendurchschnitt

15.117

51.748

EPS

0.291

Gewinnspanne

7.329

Angestellte

1,800

EBITDA

-168M

14M

Empfehlungen

By TipRanks

Empfehlungen

Buy

12-Monats-Prognose

+33.39% upside

Dividenden

By Dow Jones

Nächstes Ergebnis

23. Juli 2025

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-596M

5.2B

Vorheriger Eröffnungskurs

30.81

Vorheriger Schlusskurs

29.4

Nachrichtenstimmung

By Acuity

50%

50%

142 / 381 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Weak Bullish Evidence

Alkermes PLC Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

15. Juni 2025, 23:40 UTC

Akquisitionen, Fusionen, Übernahmen

Santos Gets $18.72 Billion Takeover Offer From Adnoc-Led Consortium -- 2nd Update

15. Juni 2025, 23:27 UTC

Akquisitionen, Fusionen, Übernahmen

Santos Gets $18.72 Billion Takeover Offer From Adnoc-Led Consortium -- Update

15. Juni 2025, 23:10 UTC

Akquisitionen, Fusionen, Übernahmen

Santos Gets $18.72 Billion Takeover Offer From Adnoc-Led Consortium

13. Juni 2025, 22:33 UTC

Akquisitionen, Fusionen, Übernahmen

Millicom to Acquire Telefonica Ecuador for $380 Million

15. Juni 2025, 23:50 UTC

Market Talk

Gold Edges Higher Amid Likely Safe-Haven Demand -- Market Talk

15. Juni 2025, 23:47 UTC

Market Talk

Nikkei May Trade Rangebound Amid Uncertainty Over Middle East -- Market Talk

15. Juni 2025, 23:41 UTC

Market Talk

Oil Rises Amid Middle East Tensions -- Market Talk

15. Juni 2025, 23:33 UTC

Market Talk

China Most Affected by Any Disruption to Iran Crude Oil Exports -- Market Talk

15. Juni 2025, 23:29 UTC

Market Talk

Oil Price Could Rise More This Week -- Market Talk

15. Juni 2025, 23:27 UTC

Market Talk

Fed's Powell Likely to Emphasize Ongoing Policy Patience -- Market Talk

15. Juni 2025, 23:27 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

15. Juni 2025, 23:02 UTC

Market Talk

Global Energy Roundup: Market Talk

15. Juni 2025, 23:02 UTC

Market Talk

Rising Middle East Tensions Could Be Passing Storm for World Economy -- Market Talk

15. Juni 2025, 22:47 UTC

Akquisitionen, Fusionen, Übernahmen

Santos Says Recommendation Requires Independent Expert Concluding Offer Is Fair, Reasonable

15. Juni 2025, 22:47 UTC

Akquisitionen, Fusionen, Übernahmen

Santos Intends to Recommend Shareholders Vote In Favor of Transaction If Binding Offer Made

15. Juni 2025, 22:46 UTC

Akquisitionen, Fusionen, Übernahmen

Santos Intends to Negotiate Terms of Process, Exclusivity Deed With XRG Consortium

15. Juni 2025, 22:46 UTC

Akquisitionen, Fusionen, Übernahmen

Santos to Give XRG Consortium Due Diligence Access

15. Juni 2025, 22:45 UTC

Akquisitionen, Fusionen, Übernahmen

Santos Says XRG Consortium Offer Is Final, Had Made Two Earlier Proposals

15. Juni 2025, 22:45 UTC

Akquisitionen, Fusionen, Übernahmen

Santos Says XRG Consortium Offering A$8.89/Share in Cash

15. Juni 2025, 22:44 UTC

Akquisitionen, Fusionen, Übernahmen

Santos Says XRG Consortium Includes Abu Dhabi Development Holding Co and Carlyle

15. Juni 2025, 22:44 UTC

Akquisitionen, Fusionen, Übernahmen

Santos Gets Takeover Offer From Consortium Led by Abu Dhabi's Adnoc

15. Juni 2025, 22:31 UTC

Market Talk

Gold Price Can Push Toward New All-Time High -- Market Talk

14. Juni 2025, 01:24 UTC

Akquisitionen, Fusionen, Übernahmen

Nippon to Close U.S. Steel Deal After National-Security Pact With Trump -- 3rd Update

13. Juni 2025, 23:50 UTC

Akquisitionen, Fusionen, Übernahmen

Trump and Nippon Steel Reach National-Security Agreement on U.S. Steel Deal -- 2nd Update

13. Juni 2025, 23:20 UTC

Akquisitionen, Fusionen, Übernahmen

Trump and Nippon Steel Reach National-Security Agreement on U.S. Steel Deal -- Update

13. Juni 2025, 23:09 UTC

Akquisitionen, Fusionen, Übernahmen

Trump, Nippon Steel Reach National-Security Agreement on U.S. Steel Deal -- WSJ

13. Juni 2025, 23:03 UTC

Akquisitionen, Fusionen, Übernahmen

Trump, Nippon Steel Reach National-Security Agreement on U.S. Steel Deal --WSJ

13. Juni 2025, 22:18 UTC

Akquisitionen, Fusionen, Übernahmen

Millicom to Acquire Telefonica Ecuador for $380M

13. Juni 2025, 22:04 UTC

Market Talk
Akquisitionen, Fusionen, Übernahmen

Better Data Facilitate Investments In Oil Patch -- Market Talk

13. Juni 2025, 21:42 UTC

Akquisitionen, Fusionen, Übernahmen

Anne Wojcicki Wins Bidding for 23andMe -- 2nd Update

Peer-Vergleich

Kursveränderung

Alkermes PLC Prognose

Kursziel

By TipRanks

33.39% Vorteil

12-Monats-Prognose

Durchschnitt 39.79 USD  33.39%

Hoch 52 USD

Tief 30 USD

Basierend auf 14 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Alkermes PLC – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

14 ratings

8

Buy

6

Halten

0

Sell

Technischer Score

By Trading Central

27.95 / 30.91Unterstützung & Widerstand

Kurzfristig

Weak Bullish Evidence

Mittelfristig

Strong Bearish Evidence

Langfristig

Strong Bullish Evidence

Stimmung

By Acuity

142 / 381 Ranking in Gesundheitswesen

Nachrichtenstimmung

Neutral

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Unterdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Alkermes PLC

Alkermes plc is a biopharmaceutical company. The Company is engaged in the researching, developing and commercializing pharmaceutical products that are designed to address medical needs of patients in therapeutic areas. The Company has a portfolio of marketed drug products and a clinical pipeline of products that address central nervous system (CNS) disorders, such as schizophrenia, depression, addiction and multiple sclerosis (MS). The Company's products include ARISTADA, VIVITROL, INVEGA SUSTENNA, XEPLION, INVEGA TRINZA, TREVICTA, RISPERDAL CONSTA, AMPYRA, FAMPYRA, BYDUREON, Aripiprazole lauroxil, ALKS 5461, ALKS 3831, ALKS 8700, ALKS 6428, ALKS 4230 and ALKS 7119. The Company's product platforms include injectable extended-release microsphere technology, LinkeRx technology, NanoCrystal technology and oral controlled release (OCR) technology. ARISTADA is an extended-release intramuscular injectable suspension for the treatment of schizophrenia.